Product Information
REPATHA 140 MG/ML SYRINGE is a brand product labeled by Amgen Inc., priced at $281.8058 per ML under NDC 72511075001. Its NADAC has been published 371 times since Jul 17, 2019.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
72511075001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
EVOLOCUMABApproval Type
Biologic (BLA)
FDA Application
BLA125522On Market Since
10/9/2018
Pharmacological Classes
Price Statistics
The NADAC for REPATHA 140 MG/ML SYRINGE has been published 371 times since Jul 17, 2019, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $281.8058 per ML |
|---|---|
| All-time high | $281.9135 (Jun 10, 2026) |
| All-time low | $216.6720 (Sep 18, 2019) |
| 52-week high | $281.9135 |
| 52-week low | $275.6225 |
| Median price | $266.0339 |
| Average price | $251.3790 |
| Largest weekly change | +5.9% (Feb 3, 2021) |
| Weeks tracked | 371 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of REPATHA 140 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for REPATHA 140 MG/ML SYRINGE, manufactured by Amgen Inc., is $281.8058 per ML (NDC 72511075001), effective Aug 19, 2026.
How has the price of REPATHA 140 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for REPATHA 140 MG/ML SYRINGE has risen 29.0%. It has been tracked across 371 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for REPATHA 140 MG/ML SYRINGE?
Since Jul 17, 2019, the NADAC for REPATHA 140 MG/ML SYRINGE has ranged from a low of $216.6720 (Sep 18, 2019) to a high of $281.9135 (Jun 10, 2026), with a median of $266.0339 per ML.
Are there cheaper alternatives to REPATHA 140 MG/ML SYRINGE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as REPATHA 140 MG/ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures REPATHA 140 MG/ML SYRINGE?
REPATHA 140 MG/ML SYRINGE (NDC 72511075001) is labeled by Amgen Inc., and CMS classifies it as a brand product.